Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats.

Hay GL, Baracz SJ, Everett NA, Roberts J, Costa PA, Arnold JC, McGregor IS, Cornish JL.

J Psychopharmacol. 2018 Dec;32(12):1369-1378. doi: 10.1177/0269881118799954. Epub 2018 Sep 27.

PMID:
30260267
2.

Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Greenwald MK.

Neurobiol Stress. 2018 Aug 11;9:84-104. doi: 10.1016/j.ynstr.2018.08.003. eCollection 2018 Nov. Review.

3.

Evidence for the use of "medical marijuana" in psychiatric and neurologic disorders.

Noel C.

Ment Health Clin. 2018 Mar 23;7(1):29-38. doi: 10.9740/mhc.2017.01.029. eCollection 2017 Jan.

4.

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.

Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P.

Epidemiol Psychiatr Sci. 2018 Aug;27(4):327-335. doi: 10.1017/S2045796018000239. Epub 2018 May 23. Review.

PMID:
29789034
5.

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.

Bhardwaj AK, Allsop DJ, Copeland J, McGregor IS, Dunlop A, Shanahan M, Bruno R, Phung N, Montebello M, Sadler C, Gugusheff J, Jackson M, Luksza J, Lintzeris N; Agonist Replacement for Cannabis Dependence (ARCD) study group.

BMC Psychiatry. 2018 May 18;18(1):140. doi: 10.1186/s12888-018-1682-2.

6.

The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers.

Hindocha C, Freeman TP, Grabski M, Crudgington H, Davies AC, Stroud JB, Das RK, Lawn W, Morgan CJA, Curran HV.

Sci Rep. 2018 May 15;8(1):7568. doi: 10.1038/s41598-018-25846-2.

7.

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.

Hindocha C, Freeman TP, Grabski M, Stroud JB, Crudgington H, Davies AC, Das RK, Lawn W, Morgan CJA, Curran HV.

Addiction. 2018 May 1. doi: 10.1111/add.14243. [Epub ahead of print]

8.

Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.

Arellano AL, Papaseit E, Romaguera A, Torrens M, Farré M.

CNS Neurol Disord Drug Targets. 2017;16(5):554-566. doi: 10.2174/1871527316666170413104516. Review.

PMID:
28412920
9.

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence.

Prud'homme M, Cata R, Jutras-Aswad D.

Subst Abuse. 2015 May 21;9:33-8. doi: 10.4137/SART.S25081. eCollection 2015. Review.

10.

Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.

Morgan CJ, Das RK, Joye A, Curran HV, Kamboj SK.

Addict Behav. 2013 Sep;38(9):2433-6. doi: 10.1016/j.addbeh.2013.03.011. Epub 2013 Apr 1.

PMID:
23685330
11.

Cannabinoids.

Grotenhermen F.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.

PMID:
16266285

Supplemental Content

Loading ...
Support Center